Statistical Analysis Methods Applied to Early Outpatient COVID-19 Treatment Case Series Data

被引:2
|
作者
Gkioulekas, Eleftherios [1 ]
Mccullough, Peter A. [2 ]
Zelenko, Vladimir [3 ]
机构
[1] Univ Texas Rio Grande Valley, Sch Math & Stat Sci, Edinburg, TX 78539 USA
[2] Truth Hlth Fdn, Tucson, AZ 85728 USA
[3] Columbia Univ, Irving Med Ctr, New York, NY 10032 USA
来源
COVID | 2022年 / 2卷 / 08期
关键词
COVID-19; SARS-CoV-2; ambulatory treatment; early treatment; mortality; hospitalization; epidemiology; biostatistics; drug repurposing; CONFIDENCE-INTERVALS; MEDICAL STATISTICS; UNITED STATES; RISK; IVERMECTIN; INFECTION; HOSPITALIZATION; REPLICATION; MORTALITY; THERAPY;
D O I
10.3390/covid2080084
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
When confronted with a public health emergency, significant innovative treatment protocols can sometimes be discovered by medical doctors at the front lines based on repurposed medications. We propose a statistical framework for analyzing the case series of patients treated with such new protocols, that enables a comparison with our prior knowledge of expected outcomes, in the absence of treatment. The goal of the proposed methodology is not to provide a precise measurement of treatment efficacy, but to establish the existence of treatment efficacy, in order to facilitate the binary decision of whether the treatment protocol should be adopted on an emergency basis. The methodology consists of a frequentist component that compares a treatment group against the probability of an adverse outcome in the absence of treatment, and calculates an efficacy threshold that has to be exceeded by this probability, in order to control the corresponding p-value and reject the null hypothesis. The efficacy threshold is further adjusted with a Bayesian technique, in order to also control the false positive rate. A random selection bias threshold is then calculated from the efficacy threshold to control for random selection bias. Exceeding the efficacy threshold establishes the existence of treatment efficacy by the preponderance of evidence, and exceeding the more demanding random selection bias threshold establishes the existence of treatment efficacy by the clear and convincing evidentiary standard. The combined techniques are applied to case series of high-risk COVID-19 outpatients that were treated using the early Zelenko protocol and the more enhanced McCullough protocol.
引用
收藏
页码:1139 / 1182
页数:44
相关论文
共 50 条
  • [21] A Statistical Non-Parametric data analysis for COVID-19 incidence data
    Minu, R.I.
    Nagarajan, G.
    ISA Transactions, 2022, 130 : 675 - 683
  • [22] A Statistical Non-Parametric data analysis for COVID-19 incidence data
    Minu, R. I.
    Nagarajan, G.
    ISA TRANSACTIONS, 2022, 130 : 675 - 683
  • [23] A Case Series Analysis of Intestinal Ischemia in Covid-19 Pandemic
    Darshan, B. M.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2023, 236 (05) : S36 - S36
  • [24] A case series analysis of intestinal ischemia in COVID-19 pandemic
    Darshan, B. M.
    Somasekhar, Kasa
    BRITISH JOURNAL OF SURGERY, 2022, 109
  • [25] On a Statistical Transmission Model in Analysis of the Early Phase of COVID-19 Outbreak
    Zhu, Yifan
    Chen, Ying Qing
    STATISTICS IN BIOSCIENCES, 2021, 13 (01) : 1 - 17
  • [26] On a Statistical Transmission Model in Analysis of the Early Phase of COVID-19 Outbreak
    Yifan Zhu
    Ying Qing Chen
    Statistics in Biosciences, 2021, 13 : 1 - 17
  • [27] Analysis of Results of JSM Reasoning Applied to Covid-19 Testees’ Data
    E. A. Efimova
    Automatic Documentation and Mathematical Linguistics, 2022, 56 : 285 - 294
  • [28] Statistical Analysis of COVID-19 Data: Using A New Univariate and Bivariate Statistical Model
    Bantan, Rashad A. R.
    Shafiq, Shakaiba
    Tahir, M. H.
    Elhassanein, Ahmed
    Jamal, Farrukh
    Almutiry, Waleed
    Elgarhy, Mohammed
    JOURNAL OF FUNCTION SPACES, 2022, 2022
  • [29] Impact of COVID-19 pandemic on outpatient antibiotics use in France: A time-series analysis using nationwide data
    Rousselot, N.
    Tchassim, B.
    Mathieu, C.
    Pariente, A.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2023, 37 : 73 - 73
  • [30] Statistical Analysis of COVID-19: Understanding the Dynamics through Medical Data
    Jiang, Hongli
    Lin, Na
    Wu, Zhandong
    Du, Hang
    WIENER KLINISCHE WOCHENSCHRIFT, 2024, 136 : S444 - S444